Leidos is focused on enhancing patient care and transforming service delivery models from bench to bedside through digital transformation to revolutionize the future of health care. And under Health Group President Jonathan Scholl’s leadership, the Leidos Partnership for Defense Health had quite the year.
Throughout the course of 2019, the partnership delivered the MHS GENESIS electronic health record system to the first of 23 deployment waves. Once complete, nearly 18 million service members, veterans and their families will have one common record for seamless care.
Leidos Partnership for Defense Health also bolstered its digital health solutions team through a contract with the nation’s fourth largest health system, Trinity Health, by adding 450 IT professionals to support health systems.
The company also launched QTC Mobile Clinics that logged more than 100,000 miles to provide independent medical exams for veterans in rural locations, and completed the acquisition of IMX Medical Management Services to expand coverage areas for high-quality medical disability exams and reviews.
The Leidos Biomedical Research team also conducted Ebola clinical trials in the Democratic Republic of Congo. As a result, many of the company’s scientists involved in the development of the vaccine were named as nominees for Journal of Science’s 2019 Breakthrough of the Year Award given to the most significant scientific development this year.
And along with the Health Group’s success, it’s Leidos’ 50-year legacy of deep engineering, novel complex systems integration, employment of bright health IT experts and high work ethic and integrity that sets the company apart, according to Scholl.
“Leidos also believes in taking care of the communities where we work and live,” he said.
Through the company’s opioid education and awareness campaign, it has distributed more than 100,000 drug deactivation kits and initiated a CEO pledge that calls on business leaders to address the opioid epidemic where their employees live and work.
“Daily, we get the opportunity to be a caregiver to all of those in need of support,” Scholl added. “It’s what motivates us each and every day.”
Why Watch:
As a health IT solutions integrator, Leidos’ culture of innovation inspires its employees to harness emerging technologies that enable mission success.
“We leverage our Leidos Innovations Center, which is outfitted with sensors and technologies that deliver intelligent automation and artificial intelligence solutions and services, to revolutionize business processes and automate commoditized low-value tasks for all federal health agencies,” Scholl said.
And the company is conducting research and development into the natural language processing of medical records that’s showing promise in the classification of veterans’ benefits claims.
But the company’s mission won’t differ in 2020: to change the way health care is delivered in the U.S.
“We’ll do this by staying in lock step with our customers’ missions, operations and platforms,” Scholl said. “We’ll also stay committed to figuring out how to put meaningful information inside the clinical workflow, leveraging AI and machine learning solutions and then applying change management to ensure everyone is working smarter.”
Leidos Health Group will look for opportunities to expand its core federal health digital transformation business into adjacent markets and leverage its technical competencies to penetrate new markets.
“Finally, we’ll continue to execute what we do best — creating and delivering solutions and services that drive improvements in patient care and efficiencies in health care delivery,” Scholl added.
1 Comment
Pingback: Top 25 Execs to Watch in 2020: Leidos’ Jonathan Scholl – Health News US